Lactiplantibacillus plantarumCCFM1019 attenuate polycystic ovary syndrome through butyrate dependent gut–brain mechanism

Jan 19, 2022Food & function

Lactiplantibacillus plantarum CCFM1019 may reduce polycystic ovary syndrome through a gut-brain process involving butyrate

AI simplified

Abstract

CCFM1019 reduced PCOS symptoms in a letrozole-induced model by restoring hormone levels and altering gut microbiota.

  • CCFM1019 alleviated ovarian pathological changes in a rat model of PCOS.
  • Restoration of testosterone and luteinising hormone levels was observed with CCFM1019 treatment.
  • Metabolic disorders induced by letrozole were not significantly reversed by CCFM1019.
  • Alterations in gut microbial diversity and increases in short-chain fatty acid producers were noted after CCFM1019 intervention.
  • Rats treated with CCFM1019 showed higher levels of butyrate and polypeptide YY compared to letrozole-treated rats.
  • A potential gut-brain mechanism involving butyrate regulation may contribute to the protective effects of CCFM1019.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free